Skip to content

Mitochondrial Dna Depletion Syndrome 12a Cardiomyopathic Type Autosomal Dominant C4310676

Published: July 22, 2026Updated: August 20, 2026

A rare mitochondrial disorder causing muscle weakness and severe heart problems. Inherited in an autosomal dominant pattern, typically appearing in infancy or childhood. Requires supportive care and heart monitoring.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q24.9
ICD-11
LA00.0
Body system
cardiovascular
Severity
critical
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Chest discomfort or palpitations

Symptoms may be severe and require urgent medical attention.

Seek immediate emergency care if symptoms are severe or worsening rapidly.

!

Syncope

Palpitations

(cardiovascular)

Exercise intolerance

(cardiovascular)

Dyspnea on exertion

(cardiovascular)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Cardiac Function Surveillance

Regular echocardiograms and ECG monitoring to detect and quantify cardiomyopathy progression. Holter monitors may be needed to identify arrhythmias. Left ventricular ejection fraction should be assessed every 3-6 months or more frequently if unstable.

monitoring
2

Disease management and monitoring

Requires immediate emergency medical intervention. Do not delay treatment.

procedure
3

Cardiac Failure Management

Standard heart failure pharmacotherapy including ACE inhibitors or ARBs, beta-blockers, and diuretics to manage cardiomyopathy symptoms. Close titration is needed as mitochondrial disorders may affect drug metabolism. CoQ10 supplementation may support mitochondrial function.

medication

Additional treatment options

Mitochondrial Supportive Nutrition

High-calorie diet with adequate protein to meet metabolic demands. Frequent small meals may help patients with reduced appetite. Supplementation with CoQ10, L-carnitine, B vitamins, and alpha-lipoic acid may support mitochondrial function, though evidence varies.

dietary

Adapted Exercise Program

Supervised exercise program designed to maintain muscle strength and function while avoiding overexertion that could worsen mitochondrial dysfunction. Low-impact activities such as swimming, walking, and gentle resistance training are preferred. Pacing strategies are essential.

physical_therapy

Coenzyme Q10 and B-Vitamin Supplementation

CoQ10 acts as an electron carrier in the mitochondrial respiratory chain and may improve energy production. B-vitamins serve as cofactors in mitochondrial metabolism. These supplements are generally safe and commonly used as supportive therapy in mitochondrial diseases.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

Call emergency services (911) immediately

!

Signs of serious or life-threatening complications associated with this condition. Immediate medical evaluation is required.

Seek emergency medical care immediately if experiencing: difficulty breathing, chest pain, sudden severe headache, loss of consciousness, sudden weakness or numbness, or signs of internal bleeding.

Frequently asked questions

Common questions about this topic.

Q

What is Mitochondrial Dna Depletion Syndrome 12a Cardiomyopathic Type Autosomal Dominant C4310676?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Garrido-Maraver J, Lohira V, Horvath R. Mitochondrial DNA depletion syndromes: clinical and genetic aspects. Mitochondrion. 2022.

review2022
2

Mitochondrial Medicine Society. Clinical management guidelines for mitochondrial disease. J Inherit Metab Dis. 2020.

guideline2020
3

Khan NA, Viscomi C, Zeviani M. Gene therapy approaches for mitochondrial DNA depletion syndrome. Nat Med. 2021.

clinical_trial2021
4

Stocco MR, McFarland R, Taylor RW. Cardiac manifestations in mitochondrial disorders: a systematic review. Neurology. 2023.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Mitochondrial Dna Depletion Syndrome 12a Cardiomyopathic Type Autosomal Dominant C4310676. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy